Monday, December 9, 2024

Bayer and Liveo Research Launch Innovative Blister Packaging with Significant Environmental Benefits

Similar articles

Key Takeaways

  • Significant reduction in carbon footprint and environmental impact.
  • Improved sustainability without additional cost.
  • Commitment to maintaining product quality and safety.
  • Collaboration with industry partners for better recycling solutions.

In a groundbreaking development for the healthcare sector, Bayer, in collaboration with Liveo Research, has introduced a new polyethylene terephthalate (PET) blister packaging for its Aleve brand. This move represents a significant shift towards sustainable packaging by reducing the carbon footprint by 38% compared to traditional packaging.

Subscribe Weekly Market Access News

* indicates required

By eliminating polyvinyl chloride (PVC), the new packaging addresses long-standing environmental concerns associated with multilayer blister packs. The initiative, which starts in the Netherlands, aims to expand globally, replacing all existing blister packs with eco-friendly alternatives.

Environmental Impact and Sustainability Efforts

Bayer’s new packaging initiative is not just about reducing carbon emissions. The PET blister packaging also decreases water use by 78% and land use by 53% per unit, significantly reducing biodiversity loss.

The packaging is lighter by 18%, which contributes to its reduced environmental impact. This innovative change results from extensive collaboration between Bayer and Liveo Research over several years.

Strategic Goals and Industry Collaboration

Chris Padain, Vice President, and Global Head of Design at Bayer’s Consumer Health division, highlighted the company’s commitment to creating consumer-friendly packaging that minimizes environmental impact.

He emphasized their goal of integrating circular solutions into their packaging strategy. Dr. Carsten Heldmann, CEO of Liveo Research, affirmed their continued support for the pharmaceutical industry to achieve sustainability goals while meeting regulatory standards.

The transition to PET blister packaging in OTC medicine represents a significant step towards sustainable practices. However, it requires parallel advancements within the recycling industry to ensure the circular economy’s success.

Bayer is actively engaging with industry partners, including the Global Self-Care Federation and The Blister Pack Collective, to advance research and development in sustainable packaging solutions. The company’s recent partnership with The Recycling Partnership further emphasizes its dedication to driving systemic change and improving recycling infrastructure.

The Sustainability Journey

As Bayer and Liveo Research advance in their sustainability journey, they set a precedent for the pharmaceutical sector, highlighting the importance of innovation in achieving environmental goals.

You can follow our news on our Telegram, LinkedIn and Youtube accounts.

The initiative not only aligns with Bayer’s mission of “Health for all, Hunger for none” but also underscores the brand’s commitment to delivering reliable and high-quality products while fostering a positive impact on the planet. Consumers and industry stakeholders can look forward to a future where sustainable solutions seamlessly integrate into everyday products, promoting environmental stewardship without compromising quality or efficacy.

 

Bayer


This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article